Physician Assistant · New Orleans, LA
NPI
1922016757
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,565
150 services
Medicare patients, 2024
82
Average age 66
Drug cost, 2024
$5.3M
781 prescriptions
Company payments, 2025
$8,479
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer B Scheuermann was code 99214 (office e&m - established), 29 times for 25 patients. In total Jennifer B Scheuermann billed 150 services in 7 codes, and Medicare paid $8,565.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 29 | 25 | $58.96 | $1,710 |
| 99214 Office E&M - Established | Office | 22 | 17 | $58.88 | $1,295 |
| 91200 Standard X-ray | Facility | 21 | 21 | $5.80 | $122 |
| 99215 Office E&M - Established | Facility | 19 | 17 | $87.49 | $1,662 |
| 99213 Office E&M - Established | Office | 13 | 12 | $44.92 | $584 |
| 99215 Office E&M - Established | Office | 13 | 11 | $96.29 | $1,252 |
By year: 2022 $9,632 for 159 services; 2023 $7,170 for 124 services; 2024 $8,565 for 150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer B Scheuermann prescribed most often to Medicare patients was Epclusa (Sofosbuvir/Velpatasvir), with 182 prescriptions and refills. In total Jennifer B Scheuermann wrote 781 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Epclusa Sofosbuvir/Velpatasvir | 182 | 182 | 68 | $4.2M |
| Vemlidy Tenofovir Alafenamide | 116 | 116 | 16 | $166K |
| Xifaxan Rifaximin | 89 | 89 | 13 | $285K |
| Lactulose Generic | 42 | 59 | 17 | $2,742 |
| Spironolactone Generic | 40 | 66 | 11 | $337 |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 40 | 40 | 16 | $332K |
| Furosemide Generic | 32 | 52 | Under 11 | $75.56 |
| Mavyret Glecaprevir/Pibrentasvir | 19 | 19 | Under 11 | $247K |
| Entecavir Generic | 18 | 26 | Under 11 | $3,488 |
| Pantoprazole Sodium Generic | 18 | 26 | Under 11 | $90.8 |
| Constulose Lactulose | 17 | 17 | Under 11 | $465 |
| Tenofovir Disoproxil Fumarate Generic | 16 | 16 | Under 11 | $464 |
| Amiloride Hcl Generic | 15 | 15 | Under 11 | $128 |
| Carvedilol Generic | 14 | 30 | Under 11 | $62.9 |
| Omeprazole Generic | 12 | 22 | Under 11 | $21.02 |
Brand drugs: 491 claims; generic drugs: 290 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer B Scheuermann $8,479 ($8,479 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $7,386.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.